Early treatment for eosinophilic esophagitis may lower children's asthma risk
Young children treated for eosinophilic esophagitis (EoE) with dupilumab were less likely to develop asthma in the future compared with children who received a different treatment. The findings come from a new study presented at the American College of Allergy, Asthma and Immunology (ACAAI) 2026 Annual Scientific Meeting. The study also appears in Annals of Allergy Asthma & Immunology.
We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.
